q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

April 2015 Summary of the Most Recent Updates for the Medicare Part D Plan Formularies (Drug Lists) Part 1

Category: Monthly Formulary Changes
Published: May, 06 2015 11:05:34
< Previous
Next >
The most recent (April 2015) Medicare Part D plan formulary data (or drug lists) updates include the addition of 360 new National Drug Codes (NDC) to the Medicare Part D program.  These represent 216 different drugs, many with multiple strengths or delivery forms. The summary below is reflective of all 360 NDCs, However, since there are so many new NDCs we need to break the NDC details chart into two parts. This blog details the first 180 NDCs.  Go to the Part 2 blog for the details of the remaining 180 NDCs.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is a follows:


Reason for NDC Addition Occurrences
New Delivery Form 10
New Delivery Form and Strength 16
New Drug 76
New Drug and Delivery Form 6
New Drug and Strength 121
New Drug, Manufacturer, Delivery Form and Strength 5
New Drug, Strength and Delivery Form 3
New Manufacturer 6
New Manufacturer and Delivery Form 6
New Manufacturer and Delivery Form and Strength 21
New Manufacturer and Strength 32
New Package 1
New Strength 57
Total New NDCs 360

The following 180 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area. Go to the Part 2 blog for links to the drug in the remaining 180 new NDCs.

NDC Drug Name Notes
49884001002 ACCOLATE 10 MG TABLET new drug and strength
49884001102 ACCOLATE 20 MG TABLET new drug and strength
13551021001 ACIPHEX SPRINKLE DR 10 MG CAP new manufacturer, strength and delivery form
13551020501 ACIPHEX SPRINKLE DR 5 MG CAP new manufacturer, strength and delivery form
63459050230 ACTIQ 200MCG LOZENGE new strength
57844010501 ADDERALL 5 MG TABLET new strength
00024588236 AFREZZA 30-4 UNIT + 60-8 UNIT new drug and strength
00024587490 AFREZZA 4 UNITS CARTRIDGE INH new drug and strength
00024588463 AFREZZA 60-4 UNIT + 30-8 UNIT new drug and strength
62856079601 AKYNZEO 300-0.5 MG CAPSULE new drug
24658016271 Alendronate sodium 35 mg tab new manufacturer and strength
00409420003 AMINOSYN 7%-ELECTROLYTE SOL new strength
00409416603 Aminosyn RF 600; 429; 462; 726; 535; 726; 726; 330; 165; 528mg/100mL; mg/100mL; mg/100mL; mg/100mL; new strength
49884057511 AMLODIPINE-VALSARTAN 10-160 MG new drug and strength
49884057711 AMLODIPINE-VALSARTAN 10-320 MG new drug and strength
49884057411 AMLODIPINE-VALSARTAN 5-160 MG new drug and strength
49884057611 AMLODIPINE-VALSARTAN 5-320 MG new drug and strength
00093781056 AMLOD-VALSA-HCTZ 10-160-12.5 MG [EXFORGE HCT] new drug and strength
00093703856 AMLOD-VALSA-HCTZ 10-160-25 MG [EXFORGE HCT] new drug and strength
00093780956 AMLOD-VALSA-HCTZ 10-320-25 MG [EXFORGE HCT] new drug and strength
00093780756 AMLOD-VALSA-HCTZ 5-160-12.5 MG [EXFORGE HCT] new drug and strength
00093703756 AMLOD-VALSA-HCTZ 5-160-25 MG [EXFORGE HCT] new drug and strength
00051846231 ANDROGEL 1.62%(1.25G) GEL PCKT new strength
00051846230 ANDROGEL 1.62%(2.5G) GEL PCKT new strength
00051842530 Androgel 10mg/g 30 PACKET in 1 CARTON / 2.5 g in 1 PACKET new package
00051848888 Androgel 10mg/g 2 BOTTLE, PUMP in 1 CARTON / 75 g in 1 BOTTLE, PUMP new strength
00462039430 ApexiCon 0.5mg/g 1 TUBE in 1 CARTON / 30 g in 1 TUBE new manufacturer and strength
00187581230 APLENZIN ER 522 MG TABLET new strength
63717087001 ARBINOXA 4 MG TABLET new drug and delivery form
63717087116 ARBINOXA 4 MG/5 ML LIQUID new drug and delivery form
00173087410 ARNUITY ELLIPTA 100 MCG INH new drug and strength
00173087610 ARNUITY ELLIPTA 200 MCG INH new drug and strength
00085433301 ASMANEX HFA 100 MCG INHALER new drug and strength
00085433401 ASMANEX HFA 200 MCG INHALER new drug and strength
00085134107 ASMANEX TWISTHALER 220 MCG #30 new strength
17478021515 Atropine 1% eye drops new drug
50102012001 AUBRA-28 TABLET new drug
59922063101 AURYXIA 210 MG TABLET new drug
00037663104 AVC 15% CREAM new drug
67979051143 AVEED 750 MG/3 ML VIAL new drug
68152010809 BELEODAQ 500 MG VIAL new drug
00006003330 BELSOMRA 10 MG TABLET new drug and strength
00006032530 BELSOMRA 15 MG TABLET new drug and strength
00006033530 BELSOMRA 20 MG TABLET new drug and strength
00006000530 BELSOMRA 5 MG TABLET new drug and strength
00187519025 BENZACLIN GEL new drug
59385001230 BUNAVAIL 2.1-0.3 MG FILM new drug and strength
59385001430 BUNAVAIL 4.2-0.7 MG FILM new drug and strength
59385001630 BUNAVAIL 6.3-1 MG FILM new drug and strength
59011075704 BUTRANS 7.5 MCG/HR PATCH new drug
00310653004 BYDUREON 2 MG PEN INJECT new delivery form
00310652401 BYETTA 10 MCG DOSE PEN INJ new drug and strength
00310651201 BYETTA 5 MCG DOSE PEN INJ new drug and strength
00456141030 Bystolic 10mg/1 30 TABLET BOTTLE new strength
00456140230 Bystolic 2.5mg/1 30 TABLET BOTTLE new strength
13913001119 CAMBIA 50 MG POWDER PACKET new drug
00187204730 CARDIZEM LA 240 MG TABLET new strength
00187204890 CARDIZEM LA 300 MG TABLET new strength
00093716501 CELECOXIB 100 MG CAPSULE [Celebrex] new drug and strength
00093716601 CELECOXIB 200 MG CAPSULE [Celebrex] new drug and strength
00093717006 CELECOXIB 400 MG CAPSULE [Celebrex] new drug and strength
00093730606 CELECOXIB 50 MG CAPSULE [Celebrex] new drug and strength
58468022001 CERDELGA 84 MG CAPSULE new drug
00069547401 CEREBYX 500 MG PE/10 ML VIAL new drug
50419078901 CIPRO XR 1,000 MG TABLET new strength
50419078801 CIPRO XR 500 MG TABLET new strength
67457045010 Cladribine 10 mg/10 ml vial new drug
16781046275 CLINDAGEL 1% GEL new drug
00338111504 CLINIMIX E 880; 489; 33; 10; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77 new strength
43538095004 Clodan 0.05% shampoo new drug
00024586001 CLOLAR 20 MG/20 ML VIAL new drug
00093301019 CLOZAPINE ODT 100 MG TABLET new strength
00093301101 CLOZAPINE ODT 12.5 MG TABLET new strength
00093301219 CLOZAPINE ODT 25 MG TABLET new strength
00143301801 COLCHICINE 0.6 MG CAPSULE new drug and strength
66993016502 COLCHICINE 0.6 MG TABLET new drug and strength
76218121907 Cyclobenzaprine 7.5 mg tablet new strength
57970010001 DALVANCE 500 MG VIAL new drug
16714044004 DEBLITANE 0.35 MG TABLET new drug
51660057286 Delyla-28 tablet new drug
00037351001 DEMADEX 10 MG TABLET new strength
00037350501 DEMADEX 5 MG TABLET new strength
00187518260 DERMATOP 0.1% CREAM new delivery form
00378729653 DESOGESTR-ETH ESTRAD new drug
52054021610 Dexedrine 10 mg tablet new strength
52054021510 Dexedrine 5 mg tablet new strength
00093555001 DEXMETHYLPHENIDATE ER 5 MG CAP new strength
00378615510 Digitek 125 mcg tablet new drug and strength
00378615610 Digitek 250 mcg tablet new drug and strength
47335067581 DILTIAZEM 24HR ER 120 MG CAP new strength
68084005490 DILTIAZEM 24HR ER 240 MG CAP new strength
68025006630 DIVIGEL 0.5 MG GEL PACKET new drug
63323013017 Doxy 100 vial new drug
00145237105 DUAC 50; 10mg/g; mg/g 1 TUBE in 1 CARTON / 45 g in 1 TUBE new drug
60631004030 EDARBI 40 MG TABLET new manufacturer and strength
60631041230 EDARBYCLOR 40-12.5 MG TABLET new manufacturer and strength
60793043720 EMBEDA ER 100-4 MG CAPSULE new drug and strength
60793043020 EMBEDA ER 20-0.8 MG CAPSULE new drug and strength
60793043120 EMBEDA ER 30-1.2 MG CAPSULE new drug and strength
60793043320 EMBEDA ER 50-2 MG CAPSULE new drug and strength
60793043420 EMBEDA ER 60-2.4 MG CAPSULE new drug and strength
60793043520 EMBEDA ER 80-3.2 MG CAPSULE new drug and strength
00378072301 Enalapril Maleate and Hydrochlorothiazide 10; 25mg/1; mg/1 100 TABLET BOTTLE, PLASTIC new strength
00093578698 ENTECAVIR 0.5 MG TABLET [Baraclude] new drug and strength
00093578756 ENTECAVIR 1 MG TABLET [Baraclude] new drug and strength
51991083675 EPINASTINE HCL 0.05% EYE DROPS new drug
54505010101 Epinephrine 0.15 mg auto-injct new drug
64116012101 ESBRIET 267 MG CAPSULE new drug
00378464426 Estradiol 0.025 mg patch new delivery form and strength
00378464326 Estradiol 0.0375 mg patch new delivery form and strength
00378464226 Estradiol 0.05 mg patch new delivery form and strength
00378464126 Estradiol 0.075 mg patch new delivery form and strength
00378464026 Estradiol 0.1 mg patch new delivery form and strength
40076006100 EVOCLIN 1% FOAM new drug
00078056130 EXFORGE HCT 10-160-12.5 MG TAB new drug and strength
00078056230 EXFORGE HCT 10-160-25 MG TAB new drug and strength
00078056330 EXFORGE HCT 10-320-25 MG TAB new drug and strength
00078055930 EXFORGE HCT 5-160-12.5 MG TAB new drug and strength
00078056030 EXFORGE HCT 5-160-25 MG TAB new drug and strength
16714035901 FALMINA-28 TABLET new drug
00310621030 FARXIGA 10 MG TABLET new manufacturer and strength
00430001005 FEMCON FE CHEWABLE TABLET new drug
60758088005 Fluorometholone 0.1% drops new drug
66530025830 FLUOROURACIL 0.5% CREAM new manufacturer and strength
00093718856 Fluoxetine 10mg/1 30 FILM COATED TABLETS in BOTTLE new manufacturer and strength
00378073593 FLUOXETINE HCL 20 MG TABLET new manufacturer and strength
00185004709 Fosinopril Sodium 40mg/1 90 TABLET BOTTLE new manufacturer and strength
00264935055 FREAMINE HBC INJECTION new drug
00409963104 Furosemide 10mg/mL 10 CARTON in 1 CONTAINER / 1 SYRINGE, PLASTIC in 1 CARTON / 4 mL in 1 SYRINGE, P new manufacturer
00574407205 Garamycin 0.3% eye drops new drug
00006410902 GARDASIL SYRINGE new delivery form
00006412102 GARDASIL 9 SYRINGE new delivery form and strength
00006411903 GARDASIL 9 VIAL new strength
00603760602 Gildess 1.5 mg-30 mcg tablet new drug
00228285011 Guanfacine hcl er 1 mg tablet new manufacturer and strength
00228285111 Guanfacine hcl er 2 mg tablet new manufacturer
00228285311 Guanfacine hcl er 3 mg tablet new manufacturer and strength
00228285511 Guanfacine hcl er 4 mg tablet new manufacturer and strength
61958180101 HARVONI 90-400 MG TABLET new drug
00074634702 HUMIRA 10 MG/0.2 ML SYRINGE new delivery form
00713070389 HYCET 7.5 MG-325 MG/15 ML SOLN new drug
13811065710 Hydrocodone Acetaminophen 2.5-325 new manufacturer and strength
53746011005 Hydrocodone Acetaminophen 325; 10mg/1; mg/1 500 TABLET BOTTLE new manufacturer and strength
00406333201 HYDROMORPHONE HCL ER 32 MG TAB new strength
59011027660 HYSINGLA ER 100 MG TABLET new drug and strength
59011027760 HYSINGLA ER 120 MG TABLET new drug and strength
59011027160 HYSINGLA ER 20 MG TABLET new drug and strength
59011027260 HYSINGLA ER 30 MG TABLET new drug and strength
59011027360 HYSINGLA ER 40 MG TABLET new drug and strength
59011027460 HYSINGLA ER 60 MG TABLET new drug and strength
59011027560 HYSINGLA ER 80 MG TABLET new drug and strength
00574402311 ILOTYCIN 0.5% EYE OINTMENT new drug
00173087310 INCRUSE ELLIPTA 62.5 MCG INH new drug
00085435101 INTRON A 18 MILLION UNITS VIAL new strength
00085435201 INTRON A 50 MILLION UNITS VIAL new strength
50458054360 INVOKAMET 150-1,000 MG TABLET new drug and strength
50458054260 INVOKAMET 150-500 MG TABLET new drug and strength
50458054160 INVOKAMET 50-1,000 MG TABLET new drug and strength
50458054060 INVOKAMET 50-500 MG TABLET new drug and strength
49281086088 IPOL SINGLE DOSE SYRINGE new delivery form
42799080601 IVERMECTIN 3 MG TABLET [Stromectol, Sklice] new drug
00597015290 JARDIANCE 10 MG TABLET new drug and strength
00597015390 JARDIANCE 25 MG TABLET new drug and strength
59212065860 KAPVAY ER 0.1 MG TABLET new drug
55724011121 KERYDIN 5% TOPICAL SOLUTION new drug
00006302901 KEYTRUDA 50 MG VIAL new drug
00310612560 KOMBIGLYZE XR 2.5-1,000 MG TAB new drug and strength
00310614530 KOMBIGLYZE XR 5-1,000 MG TAB new drug and strength
00310613530 KOMBIGLYZE XR 5-500 MG TABLET new drug and strength
54838056670 Lamivudine 10 mg/ml oral soln new manufacturer, strength and delivery form
16714040701 LARIN 1.5 MG-30 MCG TABLET new strength
50458092050 LEVAQUIN 250mg/1 50 FILM COATED TABLETS in BOTTLE new strength
00472023516 Levetiracetam 100mg/mL 473 mL in 1 BOTTLE, PLASTIC new manufacturer
00591363560 Levetiracetam 500mg/1 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC new manufacturer
68180011807 LEVETIRACETAM ER 750 MG TABLET new manufacturer
42543071290 LEVOCETIRIZINE 5 MG TABLET new manufacturer
00703906033 Linezolid 600 mg/300 ml iv sol [Zyvox] new drug
62559028001 LITHOBID ER 300 MG TABLET new drug
16781039204 LOCOID 0.1% LOTION new drug and delivery form
16781038915 LOCOID 0.1% OINTMENT new drug and delivery form
Go to the Part 2 blog for links to the remaining NDCs.

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.